4-(Chloromethyl)pyrimidine → 2-(Pyridazin-3-ylmethyl)isoindoline-1,3-dione
Reaction equation
ClCC1C=CN=CN=1.Cl[CH2:10][C:11]1[N:12]=[N:13][CH:14]=[CH:15][CH:16]=1.[C:17]1(=[O:27])[NH:21][C:20](=[O:22])[C:19]2=[CH:23][CH:24]=[CH:25][CH:26]=[C:18]12.[K]>>[N:13]1[CH:14]=[CH:15][CH:16]=[C:11]([CH2:10][N:21]2[C:17](=[O:27])[C:18]3[C:19](=[CH:23][CH:24]=[CH:25][CH:26]=3)[C:20]2=[O:22])[N:12]=1Participants
4
Procedure
Following the procedure as described in step A of Preparation 14, making variations as required to replace 4-(chloromethyl)pyrimidine with 3-(chloromethyl)pyridazine (prepared according to R. W. Carling, et al., J. Med. Chem., (2004), Vol. 47, pp. 1807-1822) to react with potassium phthalimide, 2-(pyridazin-3-ylmethyl)isoindoline-1,3-dione was obtained as a colorless solid in 17% yield: 1H NMR (300 MHz, CDCl3) δ 9.12 (d, J=3.0 Hz, 1H), 7.90-7.85 (m, 2H), 7.78-7.72 (m, 2H), 7.51-7.43 (m, 2H), 5.21 (s, 2H):MS (ES+) m/z 240.1 (M+1).
Workup
- customas described in step A of Preparation 14
- customprepared
Sources & evidence
- ORD record
- ord-9bdfefe33d2542aaa2ef2db533555412
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08063084B2
Reaction notes
Loading…